The Sexual Health And genito-Pelvic pain knowledge Empowerment Hub (SHAPE) is a pan-Canadian initiative dedicated to addressing the barriers to evidence-based information and treatment for sexual difficulties and genito-pelvic pain that affect the lives of countless individuals, especially women and gender-diverse people.

These issues are not only pervasive but are often accompanied by numerous barriers that hinder access to effective care and support. SHAPE’s goal is to mobilize knowledge, promote inclusivity, and create an equitable, culturally sensitive approach to sexual and genito-pelvic pain health. SHAPE has partnered with the Sex Information and Education Council of Canada (SIECCAN) to share knowledge about these conditions on their website.

These issues are not only pervasive but are often accompanied by numerous barriers that hinder access to effective care and support. SHAPE’s goal is to mobilize knowledge

about

Sexuality is a fundamental component of quality of life for many people, and is associated with physical, psychological, and spiritual well-being. Yet sexual difficulties (SD) and genito-pelvic pain (GPP) are common issues that affect many peoples’ experiences and their health, and there are numerous barriers to effective care. Canada’s healthcare system has major inequities that directly affect women and gender-diverse persons with regard to sexual dysfunction and genito-pelvic pain.

Towards the goal of closing these gaps, the SHAPE Hub unites researchers, clinicians, patient partners, trainees and other knowledge users to mobilize knowledge about SD/GPP in women and gender-diverse individuals.

Overall, SHAPE will close the significant gap women and gender-diverse people face when attempting to access information about and treatment for SD/GPP

our mission

SHAPE aims to improve women’s health outcomes by addressing critical gaps in knowledge and care related to sexual dysfunction (SD) and genito-pelvic pain (GPP) through:

  1. Making existing research accessible to the public, patients, and healthcare providers and promoting equitable, evidence-based, gender-sensitive, and culturally-safe care.
  2. Maximizing research impact, ensuring that research findings are integrated into health policies and decision-making processes. This includes:
    • Identifying barriers faced by Canadian healthcare providers in managing SD/GPP.
    • Providing specialized training on SD/GPP for healthcare providers
  3. Community-driven research, to prioritize research areas and center the voices of diverse and systemically-oppressed individuals with lived experience of SD/GPP.This will be done in partnership with: (1) Indigenous and Two-Spirit peoples, (2) Black women, and (3) those who suffer from post-SSRI sexual dysfunction, and then support and fund students to take up research in these priority areas. 
  4. Building the next generation of women’s health researchers through training and grant opportunities. Training in knowledge mobilization will be offered to Canadian trainees doing research in sexual health research. 

team

Leadership Team

Provincial Partners

ongoing studies

reports

#SexAfterCancer: Sharing Knowledge About a Digital Health Tool to Address Sexual Difficulties After GynecologicCancer

This campaign used social media to share evidence-based information and tools for promoting sexual health after cancer.

PSSD RPS Report

This report presents findings from a research priority‑setting study on PSSD, drawing on the experiences and priorities of people who self‑identify as living with the condition, many of whom are members of the Canadian PSSD Society. It offers reflections on the outcomes and highlights key areas for future research

media

 A selection of media articles on recent developments in sexual dysfunction and genito-pelvic pain.

newsletter signup

Signup for timely news and information about SHAPE.

Newsletter Archive 

Each month, we share the latest SHAPE news, resources and funding opportunities. Explore past newsletter issues below

Grants Awardees

Marilyn Ashley, PhD - Postdoctoral Fellow

Academic Institution : Queen's University (Department of Psychology)

SHAPE Research Project: Understanding Distress and Symptom Burden in Post-SSRI Sexual Dysfunction

Dr. Marilyn Ashley is a postdoctoral research associate with the Sexual Health Research Lab at Queen’s University and a Part-Time Professor in Psychology at the University of Ottawa. Dr. Ashley has published widely on sexual communication, digital intimacy, psychometric measurement, and 2SLGBTQ+ health. Her current projects with Dr. Caroline Pukall include a randomized controlled trial of an online pelvic health program for women with vulvodynia, clinical validation of a sexual self-concept scale, and a program of research on post-SSRI/SNRI sexual dysfunction focused on symptom trajectories and distress profiles, predictors, and bio-psycho-sexual outcomes. Across all projects, Dr. Ashley takes a person-centred approach, critically evaluating whether widely used theories and measurement tools are valid for marginalized populations and adapting them when they are not. Her work aims to center minoritized voices and develop inclusive, evidence-based tools that reflect the diversity of sexual and relational experience.

Shay Freger, MPH, MSc – PhD Candidate

Academic Institution: McMaster University (Department of Obstetrics and Gynecology)

SHAPE Research Project: Neurophysiological and Psychosocial Profiling of Persistent Sexual Dysfunction: A Cross-Condition Study of PSSD and Endometriosis-Associated CPP

Shay’s work focuses on advancing patient phenotyping in endometriosis through integration of biological, clinical, and imaging data. His doctoral research spans autonomic nervous system function, biomarker discovery using novel sampling techniques, and imaging-based characterization of endometriosis phenotypes, with the overarching aim of developing a systems-level framework for precision stratification in chronic pelvic pain. Alongside research, he is a core contributor to EndoACT Canada, supporting policy development toward a national, standards-driven response to endometriosis. He has served as a Board of Director and a Coordinator for Education & Research at The Endometriosis Network Canada (TENC), strengthening patient-facing education and community engagement. Internationally, Shay is an Ambassador for the World Endometriosis Society and has worked alongside the World Endometriosis Organization to accelerate knowledge translation and harmonize research priorities. He has authored peer-reviewed manuscripts, book chapters, and policy-oriented outputs, and his work has been recognized with institutional awards for research impact. Collectively, his scholarship and leadership aim to close the translational gap between bench, bedside, and health-system policy, advancing equitable, phenotype-informed care for people with endometriosis.

Thanh Phung, HBSc – PhD Candidate

Academic Institution: University of Toronto Mississauga (Department of Cell and Systems Biology)

Academic Institution: University of Toronto Mississauga (Department of Cell and Systems Biology) SHAPE Research Project: Sex-Specific Neural Responses to Genital Stimulation Following SSRI Exposure and Withdrawal

Thanh is a doctoral researcher at the University of Toronto Mississauga whose work centers on the development of animal models to investigate the neuroendocrine mechanisms underlying sexual reward and genital sensation. Over the course of her doctoral studies, she has independently established a mouse model of tactile genital stimulation, providing a novel framework for investigating the neuroendocrine and behavioral mechanisms of sexual motivation. Her research has yielded insightful contributions to the field, including the identification of a previously undescribed hormone-dependent sexual reflex in female mice and the discovery that, although both sexes experience genital stimulation as rewarding, females uniquely require gonadal hormones for this reward. Building on these findings, Thanh is now leveraging her model to explore how genital sensitivity, arousal, and sexual reward are altered by SSRIs, with the long-term goal of informing new approaches to understanding and addressing sexual dysfunction.